disease

CME Webast Teaches On Chronic Kidney Disease

by

OSUWexnerbloglogo2014 CME Webast Teaches On Chronic Kidney Disease. Now, dialysis has become so commonplace that we now consider it to be a routine treatment in nearly every hospital in the country. But more importantly, we now have treatments that can hold kidney failure in check and often prevent the need for dialysis. Today on MedNet, we are going to take a look at some of these new developments in the management of chronic kidney disease. I’m please to introduce today’s guest. Dr. Khaled Boubes is nephrologist and Assistant Professor of Internal Medicine at the Ohio State University.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: recognize the prevalence and importance of CKD; and realize the importance and effectiveness of SGLT2-inhibitors in halting the progression of CKD.

You’ll also learn about the following:

  • Causes of chronic kidney disease
  • New treatments for chronic kidney disease
  • Diet and chronic kidney disease
  • Blood pressure management in chronic kidney disease
  • Anti-hypertensive medication selection in chronic kidney disease
  • Acute dialysis indications
  • Chronic dialysis indications
  • Options for dialysis

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Multiple Sclerosis

by

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Multiple Sclerosis. Over the past 25 years, there have been dramatic new developments in how we treat multiple sclerosis and this is giving hope to patients who on the past had very few options. Here today to bring us up to date on the latest developments in multiple sclerosis is the Chairman of the OSU Department of Neurology, Dr. Benjamin Segal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: LEARN about the typicalclinical course of multiple sclerosis and disease modifying treatments; and LEARN about our current understanding of the pathogenesis of MS.

You’ll also learn about the following:

  • Common signs and symptoms of multiple sclerosis
  • Current concepts in multiple sclerosis treatment

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line Education Teaches Physicians About Interstitial Lung Disease

by

OSUWexnerbloglogo2014 On-line Education Teaches Physicians About Interstitial Lung Disease. Once each year, I exercise moderator’s privileges and serve as both host and presenter and so today, I’m going to be talking about a topic that is important to me, namely interstitial lung disease.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: IDENTIFY patients with undiagnosed interstitial lung disease based on clinical, radiographic, and pulmonary function test presentations; DISTINGUISH idiopathic pulmonary fibrosis from other common interstitial diseases based on radiographic and pathologic findings; and DESCRIBE the initial management of common interstitial lung diseases including idiopathic pulmonary fibrosis, non-specific interstitial pneumonitis,
hypersensitivity pneumonitis, and sarcoidosis.

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.